| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |